Company news

Share this article:

Pharmaceutical promotion measurement firm ImpactRx has acquired Paragon Research & Consulting, Inc. of West Chester, PA. Paragon is expected to apply its analytical and custom research capabilities to ImpactRx's proprietary data to evaluate of the pharmaceutical market and of individual company and brand performance.

Teva Pharmaceutical Industries announced it has entered into a definitive agreement to acquire CoGenesys, a privately held biopharmaceutical company with a broad based biotechnology platform and focused on the development of peptide- and protein-based medicines across broad therapeutic categories. CoGenesys was established in 2005 as a division within Human Genome Sciences Inc. to focus on early drug development and was spun off as an independent company in June 2006.

Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.